doi: 10.2147/tcrm.1.1.15.53606.
Principles in genetic risk assessment
Affiliations
- PMID: 18360538
- PMCID: PMC1661604
- DOI: 10.2147/tcrm.1.1.15.53606
Item in Clipboard
Principles in genetic risk assessment
Ther Clin Risk Manag.
2005 Mar.
Abstract
Risk assessment constitutes an essential component of genetic counseling and testing, and the genetic risk should be estimated as accurately as possible for individual and family decision making. All relevant information retrieved from population studies and pedigree and genetic testing enhances the accuracy of the assessment of an individual's genetic risk. This review will focus on the following general aspects implicated in risk assessment: the increasing genetic information regarding disease; complex traits versus Mendelian disorders; and the influence of the environment and disease susceptibility. The influence of these factors on risk assessment will be discussed.
Similar articles
-
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11. J Clin Oncol. 2003. PMID: 12692171
-
Bayesian risk assessment in genetic testing for autosomal dominant disorders with age-dependent penetrance.J Genet Couns. 2007 Feb;16(1):29-39. doi: 10.1007/s10897-006-9040-9. Epub 2007 Feb 13. J Genet Couns. 2007. PMID: 17295057
-
Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.J Clin Oncol. 1996 May;14(5):1730-6; discussion 1737-40. doi: 10.1200/JCO.1996.14.5.1730. J Clin Oncol. 1996. PMID: 8622094
-
Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.Cancer Invest. 2003;21(4):588-623. doi: 10.1081/cnv-120022380. Cancer Invest. 2003. PMID: 14533449 Review.
-
Risk management frameworks for human health and environmental risks.J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608. J Toxicol Environ Health B Crit Rev. 2003. PMID: 14698953 Review.
Cited by
-
Role of Fibronectin-1 polymorphism genes with the pathogenesis of intraventricular hemorrhage in preterm infants.Childs Nerv Syst. 2020 Aug;36(8):1729-1736. doi: 10.1007/s00381-020-04598-3. Epub 2020 Apr 13. Childs Nerv Syst. 2020. PMID: 32285152 Free PMC article.
-
From Genes to Geography, from Cells to Community, from Biomolecules to Behaviors: The Importance of Social Determinants of Health.Biomolecules. 2022 Oct 9;12(10):1449. doi: 10.3390/biom12101449. Biomolecules. 2022. PMID: 36291658 Free PMC article.
-
GABRG2 C588T gene polymorphisms might be a predictive genetic marker of febrile seizures and generalized recurrent seizures: a case-control study in a Romanian pediatric population.Arch Med Sci. 2018 Jan;14(1):157-166. doi: 10.5114/aoms.2016.63739. Epub 2016 Nov 17. Arch Med Sci. 2018. PMID: 29379546 Free PMC article.
References
-
- Alhenc-Gelas M, Aiach M, de Moerloose P. Venous thromboembolic disease: risk factors and laboratory investigation. Semin Vasc Med. 2001;1:81–8. - PubMed
-
- Amos J, Grody W. Development and integration of molecular genetic tests into clinical practice: the US experience. Expert Rev Mol Diagn. 2004;4:465–77. - PubMed
-
- Bobadilla JL, Macek M, Jr, Fine JP, et al. Cystic fibrosis: a worldwide analysis of CFTR mutations: correlation with incidence data and application to screening. Hum Mutat. 2002;19:575–606. - PubMed
-
- Bridge PJ. Baltimore: John Hopkins Univ Pr; 1997. The calculation of genetic risks: worked examples in DNA diagnostics.
-
- Castoldi E, Rosing J. Factor V Leiden: a disorder of factor V anticoagulant function. Curr Opin Hematol. 2004;11:176–81. - PubMed
LinkOut - more resources
Full Text Sources
